The Comparison of Diagnostic TESE and TESA in Non-obstructive Azoospermic
Launched by ROYAN INSTITUTE · Sep 27, 2010
Trial Information
Current as of May 05, 2025
Completed
Keywords
ClinConnect Summary
This study was performed on 180 men with non-obstructive azoospermia (NOA), referring to royan infertility center, according to inclusion and exclusion criteria. Testis selection (right and left) and techniques (TESE or TESA) were performed randomly in patients. For every patient based on random order, TESA or TESE was performed as the following procedures. The testis was aspirated at three separated sites (upper, middle and lower pole), using 20 ml syringe and 18-gauge needle or testicular biopsy (TESE) was taken from the same 3 sites.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Non obstructive Azoospermia
- • No Previous biopsy
- Exclusion Criteria:
- • Atrophic testis
- • FSH levels more than 4 times normal range
About Royan Institute
The Royan Institute is a leading research organization dedicated to advancing the fields of reproductive health, stem cell biology, and regenerative medicine. Established to promote scientific innovation and clinical applications, the Institute focuses on translating cutting-edge research into therapeutic solutions. With a strong commitment to ethical practices and collaboration, Royan Institute conducts rigorous clinical trials aimed at improving patient outcomes and enhancing healthcare practices globally. Through its multidisciplinary approach and state-of-the-art facilities, the Institute strives to push the boundaries of medical science and contribute significantly to the understanding and treatment of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tehran, , Iran, Islamic Republic Of
Patients applied
Trial Officials
hamid gourabi, PhD
Study Chair
President of Royan Institute
Jalil Hosseini, MD
Principal Investigator
urology investigator
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials